Reversibility of tardive dyskinesia syndrome

Tremor and Other Hyperkinetic Movements

Volumn 4, Issue , 2014, Pages

  Vinuela, Angel ^a   Kang, Un Jung ^a  

^a Department of Medicine   (United States)

Author keywords

Antipsychotics; Neuroleptics; Remission; Tardive dyskinesia

Indexed keywords

EID: 85044620915     PISSN: None     EISSN: 21608288     Source Type: Journal    
DOI: 10.5334/TOHM.217     Document Type: Editorial

References (12)

1. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Mov Disord 1986;1:193–208, doi: http://dx.doi.org/10.1002/mds.870010305.
2. Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 2012;69:1247–1256, doi: http://dx.doi.org/10.1001/archgenpsychiatry.2012.647.
3. Gardos G, Cole JO, Rapkin RM, et al. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures. Arch Gen Psychiatry 1984;41:1030–1035, doi: http://dx.doi.org/10.1001/archpsyc.1983. 01790220020003.
4. Casey DE. Tardive dyskinesia: Reversible and irreversible. Psychopharmacol Suppl 1985;2:88–97, doi: http://dx.doi.org/10.1007/978-3-642-70140-5_11.
5. Yagi G, Itoh H. Follow-up study of 11 patients with potentially reversibletardive dyskinesia. Am J Psychiatry 1987;144:1496–1498.
6. Bergen JA, Eyland EA, Campbell JA, et al. The course of tardive dyskinesia in patients on long-term neuroleptics. Br J Psychiatry 1989;154:523– 528, doi: http://dx.doi.org/10.1192/bjp.154.4.523.
7. Glazer WM, Morgenstern H, Schooler N, Berkman CS, Moore DC. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication. Br J Psychiatry 1990;157:585–592, doi: http://dx.doi. org/10.1192/bjp.157.4.585.
8. Fernandez HH, Krupp B, Friedman JH. The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up. Neurology 2001;56: 805–807, doi: http://dx.doi.org/10.1212/WNL.56.6.805.
9. Kane JM, Woerner M, Lieberman J. Tardive dyskinesia: Prevalence, incidence, and risk factors. J Clin Psychopharmacol 1988;8:52S–56S, doi: http://dx.doi.org/10.1097/00004714-198808001-00010.
10. Seeman P, Tinazzi M. Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 2013;44:178–183, doi: http://dx.doi.org/10. 1016/j.pnpbp.2013.02.011.
11. Teo JT, Edwards MJ, Bhatia K. Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis. Mov Disord 2012;12:1205–1215, doi: http://dx.doi.org/10.1002/mds.25107.
12. Zutshi D, Cloud LJ, Factor SA. Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic. Tremor Other Hyperkinet Mov (N Y) 2014;4:266.